II) 5 x 1 g 04 942 078 001
Dispase® I (neutral protease, grade I) 10 x approx. 2 mg, ≥ 20 U 04 942 086 001
X-Gal 100 mg, Not available in US 11 680 293 001
100 mg 03
as lithium-acyl phosphinate (LAP), 2,2’-azobis[2-methyl-N-and
(2-hydrox-yethyl) propionamide] (VA-086), and eosin Y have been
developed for bioprinting with enhanced cellular viability.21,60 In
the chain-growth
as lithium-acyl phosphinate (LAP), 2,2’-azobis[2-methyl-N-and
(2-hydrox-yethyl) propionamide] (VA-086), and eosin Y have been
developed for bioprinting with enhanced cellular viability.21,60 In
the chain-growth
interpretar el lenguaje de control
de impresora PCL-3
202 ba75701s07 04/2014
Spectroquant® Pharo 100 Especificaciones técnicas
7 Especificaciones técnicas
7.1 Características de medición